Asensus Surgical Inc Quick Ratio (ASXC) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Asensus Surgical Inc   (NYSE: ASXC)

Asensus Surgical Inc 's Quick Ratio

ASXC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2024, Quick Ratio fell to 0.19 below Asensus Surgical Inc average.

Within Medical Equipment & Supplies industry 175 other companies have achieved higher Quick Ratio than Asensus Surgical Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 1540 to 3319.

Explain Quick Ratio?
How much Cash & cash equivalents ASXC´s has?
What are ASXC´s Current Liabilities?




ASXC Quick Ratio (Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
Y / Y Current Liabilities Change 274.94 % 77.33 % 21.26 % 23.15 % 9.97 %
Y / Y Cash & cash equivalent Change -80.53 % -85.84 % -52.39 % -61.68 % -57.57 %
Quick Ratio MRQ 0.19 0.41 2.66 2.73 3.75
ASXC's Total Ranking # 3319 # 1540 # 637 # 601 #
Seq. Current Liabilities Change 106.97 % 52.74 % 4.17 % 13.86 % -2.11 %
Seq. Cash & cash equivalent Change -2.59 % -76.21 % 1.47 % -17.22 % -29.17 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 176
Healthcare Sector # 865
Overall Market # 3319


Quick Ratio Statistics
High Average Low
18.91 4.61 0.13
(Jun 30 2021)   (Dec 31 2012)




Financial Statements
Asensus Surgical Inc 's Current Liabilities $ 40 Millions Visit ASXC's Balance sheet
Asensus Surgical Inc 's Cash & cash equivalent $ 8 Millions Visit ASXC's Balance sheet
Source of ASXC's Sales Visit ASXC's Sales by Geography


Cumulative Asensus Surgical Inc 's Quick Ratio

ASXC's Quick Ratio for the trailling 12 Months

ASXC Quick Ratio

(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 100.95 % 33.98 % 19.91 % 19 % 14.15 %
Y / Y Cash & cash equivalent TTM Growth -67.45 % -62.73 % -54.04 % -47.73 % -38.83 %
Quick Ratio TTM 0.98 2.1 3.52 4.54 6.06
Total Ranking TTM # 3531 # 3391 # 3265 # 2829 #
Seq. Current Liabilities TTM Growth 53.53 % 18.18 % 5.02 % 5.45 % 2.36 %
Seq. Cash & cash equivalent TTM Growth -28.08 % -29.71 % -18.47 % -21.03 % -17.64 %


On the trailing twelve months basis Due to in Current Liabilities in the Q2 2024 to $39.92 millions, cumulative Quick Ratio decreased to 0.98 below the Asensus Surgical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 214 other companies have achieved higher Quick Ratio than Asensus Surgical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 3391 to 3531.

Explain Quick Ratio?
How much Cash & cash equivalents ASXC´s has?
What are ASXC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 215
Healthcare Sector # 953
Within the Market # 3531


trailing twelve months Quick Ratio Statistics
High Average Low
14.52 5.47 1.08
(Dec 31 2021)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Sanara Medtech Inc   0.53 $ 6.150  Millions$ 11.566  Millions
Boston Scientific Corporation  0.52 $ 2,913.000  Millions$ 5,576.000  Millions
Align Technology inc   0.52 $ 782.111  Millions$ 1,511.521  Millions
Pavmed Inc   0.49 $ 25.499  Millions$ 52.021  Millions
Star Equity Holdings Inc   0.49 $ 6.290  Millions$ 12.951  Millions
Strata Skin Sciences Inc  0.49 $ 5.483  Millions$ 11.301  Millions
Avanos Medical Inc   0.48 $ 92.200  Millions$ 193.800  Millions
Plus Therapeutics Inc   0.45 $ 8.435  Millions$ 18.787  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.43 $ 4.581  Millions$ 10.558  Millions
Stryker Corp  0.43 $ 1,998.000  Millions$ 4,620.000  Millions
Docgo Inc   0.43 $ 66.060  Millions$ 154.117  Millions
Teleflex Incorporated  0.43 $ 238.567  Millions$ 556.751  Millions
Smith and Nephew Plc  0.43 $ 653.000  Millions$ 1,531.000  Millions
Rosecliff Acquisition Corp I  0.43 $ 6.877  Millions$ 16.126  Millions
Adm Tronics Unlimited Inc   0.42 $ 0.469  Millions$ 1.108  Millions
Msa Safety Inc  0.42 $ 146.830  Millions$ 351.751  Millions
Nexgel Inc   0.41 $ 1.069  Millions$ 2.633  Millions
Lifestance Health Group Inc   0.38 $ 86.969  Millions$ 227.659  Millions
Atrion Corporation  0.35 $ 6.124  Millions$ 17.537  Millions
Ufp Technologies Inc   0.32 $ 16.728  Millions$ 51.787  Millions
Accuray Incorporated  0.32 $ 68.570  Millions$ 217.311  Millions
Alcon inc   0.31 $ 1,392.000  Millions$ 4,550.000  Millions
Masimo Corp  0.27 $ 129.600  Millions$ 477.000  Millions
National Vision Holdings Inc   0.27 $ 179.515  Millions$ 663.161  Millions
Prosomnus Inc   0.26 $ 5.305  Millions$ 20.019  Millions
Resmed Inc   0.26 $ 238.361  Millions$ 910.655  Millions
Baxter International Inc   0.26 $ 1,574.000  Millions$ 6,131.000  Millions
Nuwellis Inc   0.25 $ 1.023  Millions$ 4.016  Millions
Iridex Corp  0.25 $ 4.111  Millions$ 16.145  Millions
Steris Plc  0.25 $ 198.328  Millions$ 804.655  Millions

Date modified: 2026-09-26T07:09:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.